ID: ALA4288822

Max Phase: Preclinical

Molecular Formula: C39H56F3N7O9

Molecular Weight: 709.89

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCONC(=N)N)NC(=O)OCc1ccccc1)C1CCCCC1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C37H55N7O7.C2HF3O2/c1-25(2)22-30(31(45)23-32(46)40-20-18-26-12-6-3-7-13-26)41-35(48)33(28-16-10-5-11-17-28)43-34(47)29(19-21-51-44-36(38)39)42-37(49)50-24-27-14-8-4-9-15-27;3-2(4,5)1(6)7/h3-4,6-9,12-15,25,28-31,33,45H,5,10-11,16-24H2,1-2H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)(H4,38,39,44);(H,6,7)/t29-,30-,31-,33-;/m0./s1

Standard InChI Key:  ARTIPZVRVOALHG-ORIXBOIQSA-N

Associated Targets(Human)

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmepsin V 114 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 709.89Molecular Weight (Monoisotopic): 709.4163AlogP: 2.79#Rotatable Bonds: 20
Polar Surface Area: 216.99Molecular Species: BASEHBA: 8HBD: 8
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.38CX Basic pKa: 9.86CX LogP: 3.14CX LogD: 1.00
Aromatic Rings: 2Heavy Atoms: 51QED Weighted: 0.04Np Likeness Score: 0.19

References

1. Nguyen W, Hodder AN, de Lezongard RB, Czabotar PE, Jarman KE, O'Neill MT, Thompson JK, Jousset Sabroux H, Cowman AF, Boddey JA, Sleebs BE..  (2018)  Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics.,  154  [PMID:29800827] [10.1016/j.ejmech.2018.05.022]

Source